is metformin a glp-1 receptor agonist Diagram summarizing how metformin, gliclazide, agonists, Comparing Glucagon‐like peptide‐1 receptor agonists

The results add to growing evidence that the health benefits of GLP-1 drugs extend beyond the number on a scale

Or the first couple weeks

Whether you are dealing with rheumatoid arthritis (RA), psoriatic arthritis (PsA), lupus (SLE), Sjgrens disease (SD), or even osteoarthritis (OA), chronic inflammation keeps the immune system in a constant attack mode, leading to: Pain Swelling Stiffness Mobility problems Tissue and cartilage damage This chronic, ongoing inflammation not only makes joints hurt more, but it will worsen blood sugar control, fatigue, brain fog, and increase the risk of heart disease

From the incretin concept and the discovery of GLP-1 to todays diabetes therapy

Conclusion The history of GLP-1 drugs is a compelling narrative of scientific discovery translating into clinical revolution